Sclerosing Solutions

DBCAT000897Therapeutic category

Chemical agents injected into blood vessels and lymphatic sinuses to shrink or cause localized THROMBOSIS; FIBROSIS, and obliteration of the vessels. This treatment is applied in a number of conditions such as VARICOSE VEINS; HEMORRHOIDS;... A DrugBank category of 8 drugs. 6 of them are approved.

Also known as: Agents, Sclerosing · Drugs, Sclerosing · Injections, Sclerosing · Sclerosants · Sclerosing Agents
Drugs: Dextrose, unspecified form
Ethanolamine
Ethanolamine oleate
Morrhuic acid
Phenol
Polidocanol
Salicylic acid
Sodium tetradecyl sulfate

What you can answer from here — as of August 24, 2016

8DrugsEach linked to its full drug card

Listed above

18Drug targetsEvery drug–target pair in the class, with bond type

5,739Marketed productsAcross the regions we cover, with dosage forms and routes

30Routes of administrationHow the drugs in this class are given

Which targets do Sclerosing Solutions share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account